Although extracellular matrix (ECM) stiffness is an important aspect of the extracellular microenvironment and is known to direct the lineage specification of stem cells and affect cancer progression, the molecular mechanisms that sense ECM stiffness have not yet been elucidated. In this study, we show that the proline-rich linker (PRL) region of vinculin and the PRL-region-binding protein vinexin are involved in sensing the stiffness of ECM substrates. A rigid substrate increases the level of cytoskeleton-associated vinculin, and the fraction of vinculin stably localizing at focal adhesions (FAs) is larger on rigid ECM than on soft ECM. Mutations in the PRL region or the depletion of vinexin expression impair these responses to ECM stiffness. Furthermore, vinexin depletion impairs the stiffness-dependent regulation of cell migration. These results suggest that the interaction of the PRL region of vinculin with vinexin a plays a crucial role in sensing ECM stiffness and in mechanotransduction.
INTRODUCTION
Extracellular matrix (ECM) is a key component of extracellular microenvironments, which are important in determining cell morphology, behavior and fate (Geiger et al., 2009; Parsons et al., 2010) . Chemical cues, including the variety and density of ECM components, are well known to regulate cell proliferation, differentiation and migration. In addition, it has become increasingly apparent that cells respond to physical cues, such as ECM stiffness. Indeed, the cell lineage specification of stem cells is directed by ECM stiffness (Discher et al., 2009; Engler et al., 2006; Saha et al., 2008) , and increased ECM stiffness has been observed in tumor microenvironments, with a rigid microenvironment contributing to cancer progression (Schedin and Keely, 2011) . Furthermore, a gradient of ECM stiffness directs the cell migration of fibroblast cells (Lo et al., 2000) .
Focal adhesions (FAs), sites of cell-ECM adhesion, play an integral role in sensing ECM stiffness and transducing this information into biochemical signals. At FAs, transmembrane ECM receptors, integrins, are connected to the ends of actin stress fibers through various cytoplasmic proteins, including talin and vinculin. Cells sense ECM stiffness by 'pulling' on the ECM using actomyosin-generated intracellular tension through FAs and adjusting the tension that they exert accordingly (Geiger et al., 2009; Parsons et al., 2010) ; cells on rigid ECM exert higher intracellular tension than cells on soft ECM. Although some FA proteins have been suggested to engage in sensing intracellular tension (del Rio et al., 2009; Friedland et al., 2009; Sawada et al., 2006) , the signaling mechanisms by which cells sense ECM stiffness and transduce this information into biochemical signals are not well understood.
Vinculin is a cytoplasmic FA protein composed of an Nterminal head domain, a C-terminal tail domain and a proline-rich flexible linker (PRL) region that connects the vinculin head to the tail domain. The vinculin head domain associates with talinintegrin complexes, whereas the vinculin tail binds to the actin cytoskeleton. Vinculin is thought to be involved in FA-mediated mechanotransduction (Peng et al., 2011; Ziegler et al., 2006) . Indeed, higher tension is observed in areas where vinculin accumulates (Möhl et al., 2009) , and the expression of vinculin is required to maintain the intracellular contractile force (Alenghat et al., 2000; Goldmann et al., 1998; Mierke et al., 2008) . Vinculin dynamics are regulated by intracellular forces (Wolfenson et al., 2011) , and various tension strengths have been observed between the head and tail domains of vinculin (or in the PRL region) in living cells (Grashoff et al., 2010) . Thus, vinculin, particularly the PRL region, seems to play a crucial role in FA-mediated mechanotransduction; however, the details are not fully understood.
The affinity of vinculin for its binding partners, including Factin, is regulated by intramolecular interactions between the vinculin head and tail domains (Johnson and Craig, 1995) . In an 'inactive' conformation, the head domain associates with the tail domain and masks the actin-interaction sites in the latter (Bakolitsa et al., 2004; Borgon et al., 2004) , resulting in a decreased affinity for F-actin. The association of the head domain with other binding partners, including talin, reduces its affinity for the tail domain and induces a conformational change to an 'active' form, which exhibits a high affinity for F-actin (Carisey and Ballestrem, 2011; Cohen et al., 2006; Peng et al., 2011) . The activation of vinculin also induces a dynamic change in the PRL region, because the PRL-region-binding proteins vinexin b and the Arp2/3 complex preferentially bind to activated vinculin DeMali et al., 2002; Takahashi et al., 2005) . A recent study using a simulation of molecular dynamics has shown that, in addition to proteinprotein interactions, a stretching force pulling the vinculin tail domain away from the head domain can induce vinculin activation (Golji and Mofrad, 2010) .
Vinexin (also known as SORBS3) is an FA protein that we have identified as a PRL-region-binding protein (Kioka et al., 1999; Kioka et al., 2002) . Several transcriptional variants of vinexin are known; vinexin b is composed of three Src homology 3 (SH3) domains, and vinexin a contains an additional N-terminal region that includes a sorbin homology (SoHo) domain. Vinexin a, ArgBP2 (Arg-binding protein 2, also known as SORBS2) and CAP (c-Cbl-associated protein, also known as SORBS1) form a small protein family, the members of which have a SoHo domain and three SH3 domains. This family is conserved among species, including Caenorhabditis elegans, Drosophila and human . Vinexin functions as an adaptor protein and binds to various signaling and cytoskeletal proteins, including ERK, Abl, Dlg5, WAVE2 (also known as WASF2), flotillin, retinoic acid receptor and vinculin (Kimura et al., 2001; Lalevee et al., 2010; Mitsushima et al., 2006a; Mitsushima et al., 2004; Mitsushima et al., 2006b; Suwa et al., 2002; Wakabayashi et al., 2003) . The localization of vinexin b depends on vinculin expression, whereas vinexin a can localize at FAs without vinculin (Takahashi et al., 2005) . The binding of vinexin a, but not vinexin b, to the PRL region promotes the accumulation of actin at FAs in NIH3T3 cells (Kioka et al., 1999; Takahashi et al., 2005) . However, the function of vinexin in mechanotransduction is poorly understood.
In this study, we found that the PRL region of vinculin and the PRL-region-binding protein vinexin are involved in sensing ECM stiffness. We show that rigid ECM increases the level of cytoskeleton-associated vinculin. In addition, the fraction of vinculin stably localizing at FAs is larger on rigid ECM than on soft ECM. Mutation of the PRL region or the depletion of vinexin expression impairs these responses to ECM stiffness. Rigid ECM decreases the fraction of paxillin that stably localizes at FAs and this is dependent on vinculin and vinexin a expression. Inhibition of myosin II activity reduces the association of vinculin with vinexin a. Taken together, these results suggest that vinculin interaction through its PRL region with vinexin a plays a crucial role in sensing ECM stiffness and mechanotransduction.
RESULTS

Rigid ECM increases the fraction of vinculin stably localizing at FAs
If vinculin is involved in sensing ECM stiffness, then ECM stiffness would be expected to affect vinculin behavior. To examine the effects of ECM stiffness on vinculin, we first examined the localization of vinculin in wild-type (WT) mouse embryonic fibroblast (MEF) cells grown on polyacrylamide gel substrates with various levels of stiffness. Cells spread similarly on all substrates that we tested and showed similar cell areas on the different substrates (supplementary material Fig. S1A ). By using immunofluorescence microscopy we found that vinculin localized at FAs comparably on all tested substrate stiffnesses ( Fig. 1A-D) . No significant difference in the number, area or integrated intensity of vinculin-containing FAs among the cells grown on substrates of different stiffness was detected, suggesting that vinculin can localize at FAs independently of ECM stiffness under our experimental conditions. Because the actin cytoskeleton plays an essential role in mechanotransduction, we investigated the effect of substrate stiffness on the amount of vinculin included in the cytoskeletal fraction, by using treatment with cytoskeleton stabilization buffer (CSK). CSK treatment removes the cytoplasmic proteins as well as proteins that are loosely attached to the cytoskeleton from cells, whereas cytoskeletal proteins and proteins that bind tightly to the cytoskeleton are not solubilized, but remain on the substrate (Fey et al., 1984; Ruhrberg et al., 1997) . Thus, vinculin that is tightly bound to the actin cytoskeleton can be visualized by using CSK treatment followed by immunostaining. The intensity of CSK-resistant vinculin at FAs was high on rigid substrates (25 kPa and 43 kPa), whereas most vinculin was washed out on soft substrates (3.8 kPa and 7.8 kPa) (Fig. 1E) . Quantification of the immunostaining signals showed that the number of FAs that contained CSK-resistant vinculin was strongly increased in a manner that was dependent upon substrate stiffness (Fig. 1F) . The area of FAs per cell and the integrated intensity of CSK-resistant vinculin in each cell were also increased in a stiffness-dependent manner (Fig. 1G,H) . These results suggest that rigid ECM increases the fraction of vinculin that is bound to the actin cytoskeleton at FAs.
Talin is another FA protein that associates with the actin cytoskeleton. We examined the effect of ECM stiffness on the CSK resistance of talin. In contrast to vinculin, talin was washed out by CSK treatment; only slight signals were detected even on rigid substrates after CSK treatment (supplementary material Fig.  S2 ). Two other FA proteins, paxillin and FAK (also known as PTK2), were also washed out by CSK treatment, and only trace amounts of signal were detected even on rigid substrates (supplementary material Fig. S2 ). This result suggests that the effects of ECM stiffness on CSK resistance are specific to vinculin.
To corroborate the results obtained from immunostaining experiments, cells cultured on soft or rigid substrates were treated with CSK buffer and then the CSK-resistant fraction was examined by immunoblotting. Because a significant amount of vinculin is cytosolic (Lee and Otto, 1997; Sawada and Sheetz, 2002) , a substantial portion of vinculin was washed out by CSK treatment. However, as expected, CSK-resistant vinculin increased in a stiffness-dependent manner (Fig. 1I,J) . By contrast, most talin, p130CAS (also known as BCAR1) and paxillin were washed out, and only small amounts of the proteins were detected either on soft or rigid substrates. This result also suggests that rigid ECM increases the fraction of vinculin binding to the actin cytoskeleton at FAs. Intracellular tension reduces vinculin turnover at FAs (Wolfenson et al., 2011) . Therefore, we next investigated the effect of substrate stiffness on vinculin turnover at FAs by using fluorescence recovery after photobleaching (FRAP) analysis. WT MEF cells expressing GFP-vinculin were cultured on soft or rigid substrates, and FRAP analyses were then performed ( Fig. 2A ; supplementary material Movies 1, 2). The FRAP studies were limited to large peripheral FAs, which are relatively static, to minimize the contribution of FA growth or decay to the fluorescence measurements. As shown in Fig. 2A , culture of MEFs on rigid substrates decreased the maximum recovery of fluorescence and concomitantly increased the immobile fraction of GFP-vinculin at FAs. Calculation of the immobile fraction by curve-fitting the data revealed that 29%61.8% (6s.e.m.) of vinculin was immobile at FAs on rigid substrates, whereas 21%61.7% of vinculin was immobile on soft substrates (Fig. 2B) . T 1/2 , the time when the recovered intensity reaches half of the maximal recovery, was not affected by the substrate stiffness (Fig. 2C) . These results indicate that rigid ECM increases the fraction of vinculin stably localizing at FAs.
Interaction of the vinculin PRL region with vinexin a is required for stable localization of vinculin at FAs It is thought that cells sense ECM stiffness by pulling on the ECM using actomyosin-generated intracellular tension through FAs and by adjusting the tension that they exert accordingly (Geiger et al., 2009; Parsons et al., 2010) . The head of vinculin binds to the integrin-talin complex, and the vinculin tail domain binds to the actin cytoskeleton, implying a potentially important positioning of the PRL region for mechanotransduction. Indeed, various tension strengths have been observed between the head and tail domains of vinculin in living cells (Grashoff et al., 2010) . Accordingly, we focused on the PRL region. Because three proline clusters in the PRL region are conserved among species, including C. elegans and human (Kioka et al., 1999) , point mutations were introduced into the PRL region of vinculin to disrupt each proline cluster (P1 mutant, P843/844/846/847A; P2 mutant, P860/861/863/864A; and P3 mutant, P872/873/875/876/ 877A) (supplementary material Fig. S3A ). GFP-tagged versions of these mutants were introduced into MEFs and the subcellular localization of each was examined. All the vinculin mutants and WT vinculin clearly localized at FAs and colocalized with FAK (supplementary material Fig. S3B ), suggesting that the proline clusters in the PRL region are not necessary for vinculin localization at FAs. We then investigated whether these mutations affect the CSK resistance of vinculin on rigid substrates (collagen-coated glass coverslips) (supplementary material Fig. S3C ). Immunofluorescence analysis revealed that both WT and P1-mutant vinculin were detected at FAs even after CSK treatment, whereas most P2 and P3 mutants were removed after CSK treatment. Immunoblotting analysis also showed that the amount of P1 mutant in the CSK-insoluble fraction was comparable to that of WT vinculin, whereas only small amounts Fig. 1 . Localization of vinculin and CSK-resistant vinculin at FAs on substrates with various levels of stiffness. (A-H) WT MEFs were cultured on type-Icollagen-coated substrates with various levels of stiffness (3.8 kPa, 7.8 kPa, 25 kPa or 43 kPa). The cells were fixed without (A-D) or with (E-H) CSK treatment. Vinculin was visualized by using immunostaining and the gray images were inverted to increase their visibility (A,E). Insets indicate higher-magnification images of the areas indicated by dashed boxes. Scale bars: 10 mm. Thirty individual cells from three separate experiments were photographed for each condition. The quantified data are presented as box plots displaying the number, area and integrated intensity of vinculin-containing FAs per cell (B-D, F-H). For each box plot, box boundaries represent the 25th-75th percentiles, with the bars presenting the 1st and 99th percentile. n530; **P,0.001 compared with the softest gel (3.8 kPa). (I,J) WT MEFs cultured on type-Icollagen-coated substrates with various levels of stiffness were treated with CSK buffer or left untreated, then lysed with 1.5% SDS in PBS to solubilize the CSK-resistant fraction. Total protein lysates or four volumes of CSKresistant protein lysates were subjected to SDS-PAGE and immunoblotting using indicated antibodies (I). The ratio of CSK-resistant vinculin to total vinculin was quantified by using ImageJ (J). The values represent the mean6s.e.m. from three independent experiments.
of the P2 and P3 mutants were detected in the CSK-insoluble fractions (supplementary material Fig. S3D ). These results suggest that the second and third proline-rich clusters are necessary for the CSK resistance of vinculin on rigid substrates.
To further analyze the role of the PRL region, we selected the P2 mutant. First, we examined whether this mutant retained the native structure. Circular dichroism spectroscopic and sizeexclusion chromatographic analyses showed that the P2 mutation did not affect the secondary structure or the monodispersity (supplementary material Fig. S3E ; data not shown). In addition, the P2 mutant was coprecipitated with VASP, which binds to the first proline cluster in the PRL region of vinculin, comparable to WT vinculin, implying that the P2 mutation does not affect the overall protein structure (supplementary material Fig. S3F ). Next, we introduced EGFP-tagged vinculin P2 mutant into WT MEFs and performed FRAP analysis on soft and rigid substrates ( Fig. 2 ; supplementary material Movies 3, 4). On soft substrates, 21%61.3% (6s.e.m.) of the P2 mutant was immobile, comparable to WT vinculin. In contrast to the FRAP analysis of WT vinculin in which the immobile fraction of WT vinculin was larger on rigid substrates than on soft substrates, the immobile fraction of the vinculin P2 mutant was low (17%61.2%), even on rigid substrates. A similarly low immobile fraction of the vinculin P2 mutant on rigid substrates were observed in vinculin knockout (KO) MEFs (supplementary material Fig. S4A ). To further confirm the importance of the PRL region, vinculin-KO cells expressing the P2 mutant were cultured on soft or rigid substrates and then treated with CSK buffer and immunostained. As expected, incubation on rigid substrates promoted the CSK-resistance of WT vinculin, but not that of the P2 mutant (supplementary material Fig. S4B ); most P2 mutant in vinculin-KO cells was washed out by CSK buffer on rigid substrates. These results indicate that the PRL region plays a crucial role in the stiffnessdependent stabilization of vinculin at FAs.
Vinexin is a protein that we have identified as a PRL-binding protein (Kioka et al., 1999) . Our previous results indicated that the first proline cluster in the PRL region is not necessary for the interaction of vinculin with vinexin, but that the region containing the second and third proline clusters is sufficient for this interaction. These observations prompted us to test the role of vinexin in the stiffness-dependent regulation of vinculin. We first tested whether the vinculin mutants bind to vinexin by using a pulldown assay. As expected, WT and P1-mutant vinculin coprecipitated with vinexin; however, very little of the P2 or P3 mutants coprecipitated with vinexin (supplementary material Fig. S4C ), suggesting that both the second and third proline clusters are necessary for the binding of vinculin to vinexin. To investigate the role of vinexin in the stiffness-dependent regulation of vinculin, we used vinexin-KO MEFs that were isolated from vinexin-KO mice (Kioka et al., 2010) . Vinculin localized at FAs in the vinexin-KO MEFs (data not shown), similar to its localization in WT MEFs and consistent with previous observations (Kioka et al., 2010) . GFP-vinculin was introduced into vinexin-KO MEFs or WT MEFs, and FRAP analysis was performed on rigid substrates (collagen-coated coverslips). As shown in Fig. 3A ,B, the amount of the immobile fraction of vinculin in the vinexin-KO MEFs (20%61.5%) was less than that in WT MEFs (33%61.4%) on rigid substrates ( Fig. S1C ). The re-expression of vinexin a rescued the amount of the immobile fraction of vinculin at FAs (37%61.5%) (Fig. 3C,D) . Interestingly, vinexin b, a shorter variant of vinexin lacking the N-terminal half of vinexin a, failed to rescue the amount of the vinculin immobile fraction (26%61.6%). These results suggest that vinexin a, but not vinexin b, is essential for the stable localization of vinculin at FAs on rigid ECM.
To corroborate the function of vinexin in the stiffnessdependent regulation of vinculin, we performed vinculin immunostaining after CSK treatment of vinexin-KO MEFs and KO MEFs re-expressing vinexin a and vinexin b. The cells were cultured on acrylamide gels with various levels of stiffness, followed by treatment with CSK buffer and immunostaining. On soft substrates, vinculin was observed only faintly in both vinexin-KO MEFs and MEFs re-expressing vinexin a after CSK treatment (Fig. 4A ,B,D,E; supplementary material Fig. S1D) . Interestingly, the amount of CSK-resistant vinculin in the MEFs re-expressing vinexin a was increased significantly on rigid substrates, similar to WT MEFs. By contrast, the substrate stiffness did not affect the amount of CSK-resistant vinculin in the vinexin-KO MEFs. The amount of CSK-resistant vinculin in the vinexin-KO MEFs remained low, even on rigid substrates. Consistent with the results of FRAP analysis, vinexin b did not rescue the stiffness-dependence of CSK-resistant vinculin ( Fig. 4C,F; supplementary material Fig. S1D ). These findings suggest that vinexin a is necessary for the stiffness-dependent regulation of vinculin. To further confirm the role of the interaction between vinculin and vinexin a in the stiffness-dependent regulation of vinculin, the EGFP-tagged vinculin P2 mutant was introduced into vinexin-KO MEFs or MEFs re-expressing vinexin a or b, and FRAP analysis was then performed on rigid substrates (collagen-coated coverslips). In contrast to the results for WT EGFP-vinculin, which showed that the immobile fraction on rigid substrates increased following the re-expression of vinexin a in vinexin-KO MEFs (Fig. 3C,D) , the re-expression of either vinexin a or vinexin b did not affect the immobile fraction of the vinculin P2 mutant (Fig. 5) . These results indicate that the PRL region is required for vinexin-mediated vinculin stabilization at FAs on rigid substrates. Taken together, these observations suggest that the vinculin-vinexin interaction is required for the stiffness-dependent stabilization of vinculin.
Intracellular tension and rigid ECM promotes the interaction of vinculin with vinexin a
Cells exert higher intracellular tension on stiffer ECMs (Geiger et al., 2009; Parsons et al., 2010) . To examine the effect of intracellular tension on the vinculin-vinexin-a interaction, MEFs re-expressing vinexin a were treated with blebbistatin, a myosin II inhibitor, to reduce intracellular tension, then immunoprecipitation was performed with an antibody against vinexin. Without the treatment, vinculin was clearly coprecipitated with vinexin a (Fig. 6A,B) . Interestingly, treatment with blebbistatin reduced the amount of coprecipitated vinculin to 55% of the amount that was coprecipitated from untreated samples. This result suggests that intracellular tension promotes the interaction of vinculin with vinexin a. The effect of ECM stiffness on the interaction of vinculin with vinexin a was also investigated. WT MEFs were cultured on soft or rigid substrates, Fig. 3 . Vinexin a, but not vinexin b, is essential for the ECMstiffness-dependent increase in the immobile fraction of vinculin at FAs. (A,B) WT and vinexin-KO MEFs stably expressing EGFP-vinculin (WT) were cultured on 10 mg/ml type-I-collagencoated glass bottomed dishes and subjected to FRAP analysis. The normalized fluorescence recovery of EGFP-vinculin at FAs in WT MEFs (filled boxes, n558) or KO MEFs (open boxes, n552) was plotted using data from three independent experiments. The curves were drawn based on a single exponential function for each condition (A). Immobile fractions and T 1/2 were calculated from fitted curves (B). (C,D) Vinexin-KO MEFs re-expressing mock, vinexin a or vinexin b with stable expression of EGFP-vinculin (WT) were seeded onto 10 mg/ml type-I-collagen-coated glass bottomed dishes and subjected to FRAP analysis. The normalized fluorescence recovery of EGFP-vinculin at FAs in KO MEFs re-expressing mock (open boxes, n558), vinexin a (filled boxes, n556) or vinexin b (gray triangles, n556) was plotted using data from three independent experiments. The curves were drawn based on a single exponential function for each condition (C). Immobile fractions and T 1/2 were calculated from fitted curves (D). The values represent the mean6s.e.m. then cell lysates were immunoprecipitated with anti-vinexin-a specific antibody. More vinculin was coprecipitated with vinexin a in cells cultured on rigid substrates than in cells cultured on soft substrates (Fig. 6C) . Interestingly, a comparable amount of vinculin was coprecipitated when the anti-vinexin antibody that recognizes both vinexin a and b was used for immunoprecipitation (data not shown). This is consistent with the FRAP analysis and CSK resistance assay, in which vinexin a, but not vinexin b, plays a role in vinculin stabilization on rigid ECM. Taken together, these observations suggest that intracellular tension and rigid ECM promotes the interaction of vinculin with vinexin a.
Vinexin changes the affinity of vinculin for F-actin by inducing a conformational change of vinculin
The increase in the CSK resistance of vinculin on rigid substrates in a vinexin-a-dependent manner raises the possibility that the interaction with vinexin a enhances the affinity of vinculin for the actin cytoskeleton. Because the affinity of vinculin for F-actin is regulated by its conformation, the effect of vinexin a on the conformation of vinculin was examined by fluorescence resonance energy transfer (FRET) analysis using a vinculin-tail FRET probe, which can report changes in vinculin conformation that are caused by actin binding . FRET occurs efficiently when vinculin is in an inactive conformation, whereas FRET efficiency is low when vinculin is in an active conformation. Both the vinculin tail probe and vinexin aDN, which lacks the N-terminal 156 amino acids but retains similar effects on the actin cytoskeleton in MEFs and NIH3T3 cells (data not shown), were expressed in and purified from Escherichia coli (Fig. 7A) . The talin VBS3 (vinculin binding site 3) peptide was used as a positive control that induces the conformational change of the vinculin head and, together with F-actin, induces the activation of full-length vinculin . The VBS3 peptide (1.4 mM) decreased the corrected FRET (cFRET) ratio by 15.7% compared with the ethanol control. The addition of vinexin aDN (0.5 mM) in the presence of F-actin decreased the emission ratio by 8.1% (P,0.001, Fig. 7B-D) . As expected, vinexin aDN did not significantly affect the cFRET ratio of the FRET probe containing the P2 mutation, whereas VBS3 decreased the cFRET ratio of the P2-mutant probe to a similar extent as observed for the WT probe. We also performed an actin co-sedimentation assay using vinculin and vinexin aDN. As shown in Fig. 7E , vinexin aDN indeed increased the amount of vinculin that co-sedimented with actin in a dose-dependent manner, supporting the notion that the binding of vinexin a can promote the association of vinculin with actin. Interestingly, vinexin aDN itself was co-sedimented with actin (data not shown). Thus, the formation of the ternary complex can also contribute to the increase in the amount of vinculin cosedimented with actin. Taken together, these results indicate that the binding of vinexin a can enhance the conformational change of vinculin to an active form.
Substrate stiffness regulates the stable localization of paxillin at FAs in a vinexin-dependent manner
If the interaction of vinculin with vinexin a is involved in sensing ECM stiffness, ECM-stiffness-dependent events, such as the stiffness-dependent regulation of other FA proteins, would be expected to require this interaction. To test this possibility, we focused on another FA protein, paxillin. GFP-paxillin was introduced into WT MEFs, and a FRAP analysis was performed on substrates with various levels of stiffness (supplementary material Movies 7, 8). In contrast to vinculin, the immobile fraction of which was increased on rigid ECM (Fig. 2) , the paxillin immobile fraction was reduced on rigid ECM (Fig. 8A,B) ; the amount of the paxillin immobile fraction at FAs on rigid ECM (24%61.2%, 6s.e.m.) was less than on soft ECM (32%61.1%). T 1/2 was slightly lower on rigid ECM (23.4 s60.93 s) than on soft ECM (27.7 s61.17 s). To Fig. 5 . FRAP analysis of the P2 mutant at FAs in vinexin-KO MEFs re-expressing vinexin a or b. KO MEFs re-expressing mock, vinexin a or vinexin b with stable expression of the EGFP-tagged vinculin P2 mutant (P2) were cultured on 10 mg/ml type-I-collagencoated glass bottomed dishes and subjected to FRAP analysis. The normalized fluorescence recovery of EGFP-vinculin (P2) at FAs in KO MEFs re-expressing mock (open boxes, n547), vinexin a (filled boxes, n546) or vinexin b (gray triangles, n553) was plotted using data from three independent experiments. The curves were drawn based on a single exponential function for each condition (A). Immobile fractions and T 1/2 were calculated from fitted curves (B). The values represent the mean6s.e.m. Fig. 6 . Coimmunoprecipitation of vinculin with vinexin a. (A) KO MEFs re-expressing mock or vinexin a were treated with 5 mg/ml blebbistatin for 1 h. The cell lysate was subjected to immunoprecipitation (IP) with antivinexin antibody. Coprecipitated proteins were visualized by immunoblotting using anti-vinexin or anti-vinculin antibodies. (B) The amount of vinculin that coprecipitated with vinexin in A was quantified by using ImageJ. The values represent the mean6s.e.m. from three independent experiments. (C) WT MEFs were cultured on soft (2.7 kPa) or rigid (42 kPa) substrates for 12 hours. The cells were lysed with lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40 and 0.5% sodium deoxycholate), followed by immunoprecipitation with the anti-vinexin a specific antibody. Coprecipitated proteins were visualized by immunoblotting using anti-vinexin or anti-vinculin antibody. Results are representative of triplicate experiments. investigate whether vinexin is necessary for the lower immobile fraction of paxillin on rigid ECM, GFP-paxillin was introduced into vinexin-KO MEFs or MEFs re-expressing vinexin a or b, and a FRAP analysis was performed on rigid substrates (collagencoated coverslips). The immobile fraction of paxillin at FAs was low (23%61.0%) in the MEFs re-expressing vinexin a, and was comparable to the WT MEFs (Fig. 8C,D) . By contrast, the immobile fraction of paxillin was high (34%61.1%) in the vinexin-KO MEFs. Interestingly, vinexin b had no effect, as observed for the immobile fraction of vinculin; the immobile fraction of paxillin was 30%61.1% in cells re-expressing vinexin b. Next, we investigated the effect of the expression of vinexin a on the paxillin immobile fraction in vinculin-KO MEFs and found that the overexpression of vinexin a did not affect the immobile fraction of paxillin in these cells, indicating a requirement for vinculin in the regulation of paxillin (data not shown). Taken together, these results suggest that the vinculinvinexin-a interaction is required for the decrease in the immobile fraction of paxillin on rigid ECM.
The above observations raise the further possibility that the molecular composition of FAs is altered by ECM stiffness through the vinculin-vinexin interaction. To test this hypothesis, the effect of ECM stiffness on the ratio of paxillin to vinculin at FAs was examined by using MEFs stably expressing GFP-vinculin and mCherry-paxillin (Fig. 8E) . The ratio of mCherry-paxillin to GFP-vinculin decreased significantly in the WT MEFs grown on rigid ECM compared with cells grown on soft ECM. By contrast, the ratio of mCherry-paxillin to GFPvinculin was not altered significantly by ECM stiffness in vinexin-KO MEFs. These results suggest that ECM stiffness alters the molecular composition of FAs by regulating the immobilization of multiple proteins at FAs in a manner that is dependent on the vinculin-vinexin-a interaction.
Stiffness-dependent regulation of cell migration involves vinexin
To demonstrate the physiological role of the vinculin-vinexin interaction in sensing ECM stiffness, we performed an in vitro wound healing assay on soft or rigid substrates using WT or vinexin-KO MEFs. As shown in Fig. 8F , WT MEFs migrated significantly faster and closed the wounded region more efficiently on rigid substrates than on soft substrates (supplementary material Movies 9-12). This indicates that ECM stiffness regulates the migration of MEFs. In contrast to WT MEFs, vinexin-KO MEFs migrated slowly even on rigid substrates, similar to their migration on soft substrates; no significant difference in the migration of vinexin-KO MEFs between soft and rigid substrates was observed. These results 1 mM) and 0.5 mM GST or GST-vinexin-aDN were incubated with pre-polymerized F-actin and then spectra were measured. Talin VBS3 peptide (1.4 mM) with F-actin was used as a positive control. The mean spectra were normalized to the emission of probes at 476 nm. (D) The ratio of cFRET signal to CFP signal was calculated. EtOH, ethanol. The values represent the mean6s.e.m.; n54; n.s., non-significant; *P,0.05 compared with control samples; unpaired Student's t-test. Note the slightly low cFRET:CFP ratio of P2 tail probe, possibly due to the effect of the P2 mutation in the PRL on the distance between YFP and CFP. (E) Actin co-sedimentation assay using the vinculin tail probe. Vinculin WT tail probe (0.1 mM) and GST or GST-vinexin-aDN (0 to 0.2 mM) were incubated with pre-polymerized F-actin, then the sample was ultracentrifuged at 150,000 g for 1 h. The supernatant and pellet were subjected to SDS-PAGE followed by CBB staining.
suggest that the stiffness-dependent regulation of cell migration involves vinexin.
DISCUSSION
ECM stiffness has attracted much attention as an important factor that determines cell fate and behavior. ECM stiffness directs the lineage specification of stem cells and affects cancer progression (Engler et al., 2006; Saha et al., 2008; Schedin and Keely, 2011) . However, the molecular mechanisms that sense ECM stiffness have not been elucidated. Here, we show that CSK-resistant vinculin, which associates tightly with the cytoskeletal fraction, and the immobile fraction of vinculin were increased on rigid ECM compared with soft ECM. The interaction of the vinculin PRL region with vinexin a was necessary for these stiffnessdependent behaviors of vinculin. A conformational change in vinculin from the inactive form to the active form seems to be important for this stiffness-dependent regulation of vinculin. The constitutively active vinculin mutant T12 (which is deficient in autoinhibition owing to the presence of mutations that prevent interactions between the head and tail domains) showed strong resistance to CSK treatment (data not shown), and mutations that activate vinculin increase the immobile fraction of vinculin at FAs in fibroblast cells Cohen et al., 2006; Humphries et al., 2007) . We also found that culturing cells on rigid substrates promotes the interaction of vinculin with vinexin a, and this interaction activates vinculin in vitro. Furthermore, depletion of vinexin impairs the stiffness-dependency of cell migration. These observations indicate that the vinculin activation that is induced by the interaction with vinexin a functions as a sensor for ECM stiffness. A recent report that activated vinculin can bypass the requirement for intracellular tension during FA maturation (Carisey et al., 2013 ) also supports our finding.
Cells grown on soft and rigid substrates have low and high intracellular tension, respectively. In this study, we have shown that vinculin localizes at FAs on both soft and rigid substrates comparably. Interestingly, several reports have suggested that intracellular tension is necessary for the localization of vinculin to adhesion sites. Disruption of intracellular tension by inhibiting ROCK activity impairs the localization of vinculin to FAs in osteosarcoma cells (Carisey et al., 2013) . Myosin II inhibition induces the disappearance of vinculin from paxillin-positive adhesion sites (Pasapera et al., 2010) . These observations can be explained by a two-step mechanosensing (recruitment and activation) model of vinculin function. In this model, low intracellular tension on soft substrate is sufficient to recruit vinculin to adhesion sites. Pharmacological inhibition of ROCK or myosin II completely abolishes intracellular tension, resulting in the loss of vinculin localization to adhesion sites. By contrast, high intracellular tension induced by culturing cells on rigid substrates might induce the binding of vinculin to vinexin, leading to vinculin activation. Detailed analysis under various conditions of intracellular tension needs to be performed in the future to further understand this process.
Our research revealed that rigid ECM increases the immobile fraction of vinculin but decreases that of paxillin. The reexpression of vinexin a in KO MEFs also increases the immobile fraction of vinculin but decreases that of paxillin. Similar opposing responses of vinculin and paxillin have also been reported by Wolfenson and colleagues (Wolfenson et al., 2011) , with the reduction of intracellular tension by blebbistatin treatment decreasing the immobile fraction of vinculin and increasing that of paxillin in HeLa cells. Because intracellular tensions are higher on rigid ECM than on soft ECM, our results are consistent with the observations of Wolfenson et al. The opposite responses of vinculin and paxillin indicate that ECM stiffness (as well as vinexin a) and intracellular tension do not merely stabilize entire FAs (because the immobile fraction of paxillin decreases), but rather modulate the molecular properties of FAs. Indeed, we found that the ratio of paxillin to vinculin was regulated by stiffness of the ECM (Fig. 8) .
Stretching the Triton-X-100-insoluble cytoskeleton has been reported to promote its binding to several FA proteins, including p130CAS, FAK and paxillin, but not to vinculin (Sawada and Sheetz, 2002) . Molecules that are included in the Triton-X-100-insoluble cytoskeletal fraction seem to work as sensors for stretching and as a platform for accumulating p130CAS, FAK and paxillin. Interestingly, both the buffer used in the experiments reported by Sawada and Sheetz, and the CSK buffer used in our study are based on Triton X-100, containing 0.25% and 0.5% Triton X-100, respectively. We showed that vinculin was resistant to CSK buffer but that FAK and paxillin were washed out by CSK treatment. Given that active vinculin can recruit core FA proteins including p130CAS, FAK and paxillin to adhesion sites (Carisey et al., 2013) , an attractive explanation for the nonresponsiveness of vinculin to stretching is that some fraction of vinculin remains even after treatment with Triton X-100, and that this remaining vinculin works as a sensor for stretching and a platform for the accumulation of other FA proteins. Future studies are necessary to examine this possibility.
Here, we showed that vinexin a, but not vinexin b, is involved in the ECM-stiffness-dependent regulation of vinculin. This vinexin-a-specific function is consistent with our previous observation that vinexin a, but not b, localizes to FAs in the absence of vinculin and increases the accumulation of F-actin at FAs (Kioka et al., 1999; Takahashi et al., 2005) . During the preparation of this manuscript, dCAP, a vinexin ortholog in Drosophila, was reported to regulate the assembly and function of tension-sensing structures (Bharadwaj et al., 2013) . dCAP depletion impairs chordotonal organs, resulting in deficits in vibration sensation and hearing. Interestingly, these deficits cannot be rescued by a variant that lacks the N-terminal half of dCAP, similar to vinexin b. These observations are consistent with our finding that vinexin a, but not b, plays a crucial role in mechanotransduction. More importantly, Drosophila vinculin mutants show a partially similar phenotype to dCAP mutants. Taken together, these observations indicate a role for vinculinvinexin-a interactions in mechanotransduction that is conserved between species.
While we were in the process of revising our current manuscript, Janoštiak et al. reported that the second proline cluster in the PRL region of vinculin binds to p130CAS and plays a role in the stretch-induced phosphorylation of p130CAS (Janoštiak et al., 2013) . This further supports our conclusion that the PRL region functions as a mechanosensor for ECM stiffness. They also show that the binding of p130CAS to vinculin affects the dynamics of the latter. Functional redundancy and differences between vinexin and p130CAS in PRL-dependent mechanosensing should be examined by future analysis.
In summary, here, we demonstrate that the interaction of the vinculin PRL region with vinexin a is involved in sensing ECM stiffness. In addition, the interaction of vinculin with vinexin a is enhanced by intracellular tension and induces the activation of vinculin. Thus, we propose a model in which ECM stiffness is sensed through the interaction of the vinculin PRL region with vinexin a. On soft ECM, vinculin weakly associates with F-actin or vinexin a, and low tension is applied to the vinculin PRL region. By contrast, high tension is applied to the PRL region on rigid ECM, which promotes the interaction of the PRL region with vinexin a, leading to the activation of vinculin. Activated vinculin binds to F-actin tightly and becomes immobile at FAs. This alters the FA composition and might lead to the regulation of signals and cell fate decisions.
MATERIALS AND METHODS
Antibodies and reagents
Mouse anti-vinculin, anti-paxillin and anti-GFP antibodies were purchased from Sigma Aldrich (St Louis, MO), Life Technologies (Carlsbad, CA) and Santa Cruz Biotechnology (Dallas, TX), respectively. Mouse anti-FAK and anti-p130CAS were purchased from BD Transduction Laboratories (San Jose, CA). Anti-GST antibody was obtained from GE Healthcare. Rabbit anti-vinexin polyclonal antibody was as described previously (Kioka et al., 1999) . Anti-vinexin-a antibody was generated against truncated vinexin a (amino acids 157-234, which are not included in vinexin b). Type I collagen was purchased from Nitta Gelatin (Osaka, Japan). Puromycin and blebbistatin were obtained from Sigma Aldrich. Blasticidin was from Kaken Pharmaceutical (Tokyo, Japan).
Plasmid construction
Monomeric GFP-fused vinculin (chick) (Takahashi et al., 2005) , monomeric GFP-or mCherry-(kindly provided by Roger Y. Tsien) fused paxillin (kindly provided by Hisataka Sabe), and vinexin a and b (Kioka et al., 1999) were subcloned into pCDH-EF1-IRES-puro or -blasti vector (System Biosciences, Mountain View, CA). The vinculin P1 mutant (P843A, P844A, P846A, P847A), P2 mutant (P860A, P861A, P863A, P864A) and P3 mutant (P872A, P873A, P875A, P876A, P877A) were generated by using the QuikChange Site-Directed Mutagenesis Kit [Agilent Technologies (Stratagene), Santa Clara, CA]. Vinculin tail probes were subcloned into pColdI vector (Takara Bio, Ohtsu, Japan) for purification, and vinexin aDN, which lacks the Nterminal 156 amino acids of vinexin a, was subcloned into the pColdI-GST vector (kindly provided by Chojiro Kojima) (Hayashi and Kojima, 2008) . A plasmid encoding GST-VASP (Maruoka et al., 2012 ) was a gift from Masahiro Maruoka.
Cell culture, transfection and lentivirus generation
Spontaneously immortalized MEFs were generated from WT or vinexin-KO mice (Kioka et al., 2010) by using a standard 3T3 method (Todaro and Green, 1963) . 293T cells were provided by the RIKEN BRC through the National Bio-Resource Project of MEXT, Japan. Cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS; Gibco, Life Technologies) at 37˚C under a humidified atmosphere containing 5% CO 2 . For the generation of lentivirus, pMD2.G, psPAX2 (Addgene, Cambridge, MA) and pCDH vectors were transfected into 293T cells using Lipofectamine LTX and PLUS Reagent (Life Technologies). Cells were infected with lentiviruses, followed by incubation with 1 mg/ml puromycin and/or 3 mg/ml blasticidin in DMEM supplemented with 10% FBS. To establish cells expressing GFP-vinculin and mCherry-paxillin simultaneously, a single colony was isolated and expanded.
coverslips treated with SurfaSil (Pierce, Thermo Fisher Scientific, Rockford, IL). The polyacrylamide gels were coated with 200 mg/ml type I collagen using the photoactivatable cross-linker Sulfo-SANPAH (Pierce). The gel substrates were sterilized by UV treatment before being used as substrates for cells. The elastic modulus was calibrated by atomic force microscopy (SP400, SII Nano Technology). Young's modulus, E, was obtained using a Hertz cone model (Domke and Radmacher, 1998) to fit the force curve of 0-50 nm indentations obtained by using unsharpened pyramid-tipped cantilevers with 0.02 or 0.08 N/m of spring constant (SN-AF01-S-NT, SII Nanotechnology). Measurements were averaged over multiple locations per gel. Next, the relationship between the bisacrylamide concentration and Young's modulus was estimated by fitting plots to the power-law scaling (supplementary material Fig. S1E ). The elastic modulus of the gels containing 0.05%, 0.1%, 0.3% and 0.5% bisacrylamide was estimated by atomic force microscopy as 3.8 kPa, 7.4 kPa, 25 kPa and 43 kPa (data not shown), respectively, comparable to previous reports (Tse and Engler, 2010) . Gels with 3.8 kPa and 7.4 kPa were used as soft substrates and 25 kPa or 43 kPa were used as rigid substrates.
Immunostaining and quantification of FAs
Immunostaining was performed to visualize total or CSK-resistant vinculin. For total vinculin, cells cultured on polyacrylamide gel substrates were fixed with 1.5% paraformaldehyde for 45 min. For CSKresistant vinculin, the cells were first treated with CSK buffer [0.5% Triton X-100, 10 mM PIPES pH 6.8, 50 mM NaCl, 3 mM MgCl 2 , 300 mM sucrose and complete protease inhibitor cocktail (Roche, Basel, Switzerland)] at 4˚C for 1 min, followed by fixation with 4% paraformaldehyde for 15 min. The cells were treated with 10% goat serum in PBS for blocking and were incubated with primary antibodies for 30 min and secondary antibodies for 1 h. Photographs were taken using an LSM700 confocal microscopy system equipped with diode laser beams (Carl Zeiss, Oberkochen, Germany) through an Axio Observer Z1 fluorescence microscope with a plan-apochromat 636/1.4 NA oilimmersion objective. Quantification of the number, area and integrated intensity of vinculin at FAs per cell was performed using ImageJ software.
FRAP analysis
FRAP studies were conducted on cells expressing each GFP-fused protein. The cells were incubated for 24 h on polyacrylamide gel substrates or on type I collagen (10 mg/ml)-coated glass bottomed dishes. FRAP measurements were then performed at 37˚C in DMEM supplemented with 10% FBS under a humidified atmosphere containing 5% CO 2 . Stable FAs near the cell edge were selected and each whole FA was manually encircled as region-of-interest (ROI) and photobleached with 100% 488-nm diode laser transmission of LSM700 with a planapochromat 636/1.4 NA oil-immersion objective, resulting in ,80% quenching of GFP fluorescence. Fluorescence recovery of FAs within the ROI was observed every 5 s (vinculin, 50 frames; paxillin, 40 frames after bleaching) and analyzed by using ZEN 2009 (Carl Zeiss). Two to six FAs were photobleached and the fluorescence recovery of the original image from which background was not subtracted was monitored for each FA. A minimum of ten FAs were examined per experiment and the experiments were performed three times. Therefore, recovery curves represent data from a minimum of 30 individual adhesions (n §30) from three separate experiments. Normalized FRAP curves were fitted to the single exponential function using Origin 8.5.1 software. T 1/2 was calculated from fitted curves. Immobile fractions (IM) were determined by comparing the fluorescence intensity in the photobleached region after recovery to plateau (I p ) with the intensity before photobleaching (I i ) and just after photobleaching (I 0 ), using the equation IM51006{12[I p 2I 0 / (I i 2I 0 )]}. To exclude the effect of diffused protein fluorescence, data points taken at ,10 s after photobleaching were eliminated before fitting curves.
Protein purification
The His-tagged vinculin tail probe was expressed in E. coli Rosetta (MERCK, Darmstadt, Germany) and purified as described previously (Takahashi et al., 2005) , with slight modifications. Briefly, E.coli cells were sonicated in PBS, and the proteins were purified by Histag affinity chromatography, followed by anion exchange chromatography using MonoQ HR 5/5. Because GST-vinexin-a showed very low solubility in buffers containing any detergents that we tested, we decided to use GST-vinexin-aDN instead of GST-vinexin-a. Vinexin aDN lacks the Nterminal 156 amino acids but localizes at FAs and enhances actin accumulation at FAs similar to WT vinexin a in NIH3T3 cells (data not shown). GST-vinexin-aDN was expressed in E. coli Rosetta, which were lysed with vinexin purification buffer (50 mM Tris-HCl pH 8.0, 500 mM NaCl and 10% glycerol) containing lysozyme. GST-vinexin-aDN was purified by using glutathione-Sepharose 4B resin (GE Healthcare) as described previously (Takahashi et al., 2005) .
Immunoprecipitation and pulldown assay
Immunoprecipitation was performed as described previously (Umemoto et al., 2009) . Briefly, cells were lysed with lysis buffer (1% Triton X-100 and complete protease inhibitor cocktail in PBS) unless otherwise indicated. Equal amounts of cell lysate were incubated with anti-vinexin antibody for 1 h at 4˚C, followed by further incubation with Protein-GSepharose (Sigma Aldrich). Coprecipitated proteins were subjected to immunoblotting with specific antibodies. The pulldown assay was also performed as described previously (Wakabayashi et al., 2003) . Cell lysates were incubated with purified GST-His or GST-vinexin-aDN-His for 1 h at 4˚C, followed by further incubation with glutathione-Sepharose 4B. Coprecipitated proteins were subjected to immunoblotting with specific antibodies.
In vitro FRET assay
The in vitro FRET assay was performed as described previously , with slight modifications. Briefly, purified vinexin aDN and vinculin tail probe were resuspended in FRET buffer (30 mM Tris-HCl pH 8.0, 2 mM MgCl 2 , 100 mM KCl, 0.2 mM EGTA, 0.5 mM ATP, 0.6 mM DTT and protease inhibitor cocktail). The vinculin tail probe (0.1 mM) and vinexin aDN were incubated with 4.6 mM pre-polymerized F-actin for 1 h at room temperature. The fluorescent spectrum of the vinculin tail probe in the solution was acquired by using SpectraMax M2e (Molecular Devices, Inc., Sunnyvale, CA). Spectral cross talk was calculated as described previously . CFP emission was detected at 478 nm with excitation at 436 nm, and YFP emission was detected at 526 nm with excitation at 495 nm. In this study, the value R Y was 0.050 and the value R C was 0.392. The corrected FRET ratio (cFRET) was obtained as the FRET emission at 526 nm divided by the emission at 476 nm, after correcting for the YFP and CFP cross talk.
Circular dichroism spectrometry
The secondary structure of vinculin was estimated by circular dichroism spectrometry (J-805; JASCO, Tokyo, Japan) using a 0.1-mm quartz cell (121.027-QS, Q 10 mm; JASCO) as described previously (Sato et al., 2013) . WT or P2-mutant vinculin in phosphate buffer (50 mM sodium phosphate pH 7.4) was loaded into the quartz cell, and circular dichroism spectra were recorded at 190-250 nm. The spectra of vinculin are shown after subtraction of the spectrum for vehicle alone.
Wound healing assay on gels
The wound healing assay was performed using special double well culture inserts (Ibidi, Martinsried, Germany). Each insert was placed on a polyacrylamide gel substrate with different stiffness. At 24 h after seeding, the culture inserts were gently removed and cells were then incubated at 37˚C under an atmosphere of 5% CO 2 in a chamber on an IX81 living microscopy system (Olympus, Tokyo, Japan). Photographs at 106 magnification were taken every 15 min and analyzed by ImageJ software.
Statistical analysis
Statistical analysis was performed by using one-way ANOVA (P,0.05) and the post hoc Scheffe test or unpaired Student's t-tests in Origin 8.5.1 software.
